Bang & Olufsen completes divestiture of its Czech subsidiary and announces non-cash adjustments to the balance sheet

Udgivet den 31-05-2017  |  kl. 09:06  |  

Struer, 2017-05-31 09:06 CEST (GLOBE NEWSWIRE) -- Company Announcement no. 16.27

Today, Bang & Olufsen a/s ("Bang & Olufsen") has completed the previously announced transaction with Tymphany Acoustic Technology HK Limited (Tymphany) by divesting its entire share capital in Bang & Olufsen's Czech assembly subsidiary, Bang & Olufsen s.r.o. (the "Transaction"). As a consequence of the completion of the Transaction, as well as the ongoing strategic transition to an agile and asset-light operating model, the company announces certain related non-cash adjustments to the company's balance sheet for financial year end 2016/17.

Completion of divestiture

The Transaction has now been completed and all of Bang & Olufsen's 322 Czech employees have been transferred to Tymphany as of today.

Bang & Olufsen expects to receive DKK123 million in cash payments for the Transaction resulting in an accounting gain of DKK 33 million. As part of the strategic partnership, Tymphany will produce Bang & Olufsen products in the Czech factory. Tymphany is a long standing and trusted  supplier to Bang & Olufsen. The Transaction will enable Bang & Olufsen to further strengthen its areas of core competencies within acoustics, design, craftsmanship.

Non-cash adjustments to the balance sheet for financial year end 2016/17

The Transaction forms part of Bang & Olufsen a/s' strategic transition during the financial year to an agile and asset-light operating model. The transition will result in certain extraordinary costs and non-cash adjustments in the company's balance sheet for year end 2016/17. The key adjustments are summarised below, and will be further detailed in the Annual Report for 2016/17, which will be released on 12 July 2017.

The key adjustments are related to the following items:

  • Restructuring of the Bang & Olufsen business unit done in May 2017.
  • The increased use of partnerships, especially related to TV technology and production, will result in changes in the end-to-end operating model, affecting the company's inventories and service model. Therefore, the company will record write-downs of selected parts of the company's inventories.
  • The distribution setup will continue to be optimized towards fewer, larger and stronger partners. In addition, the company will continue the journey towards fewer company owned and operated stores. The optimized distribution will result in impairments of goodwill, and write-down of tangible assets and inventory.

The above items and related implications are estimated to result in a non-cash balance sheet adjustment of DKK 120 - 130 million in the fourth quarter of the 2016/17 financial year. In addition, the above mentioned divestiture of the Czech production facilities, will result in a DKK 33 million accounting gain in the fourth quarter, resulting in a total net negative balance sheet and reported EBIT impact of DKK 90 - 100 million related to above special items as of financial year end 2016/17.

The changes will not impact the underlying EBITDAC and therefore does not impact outlook for the financial year 2016/17.

 

Henrik Clausen

CEO

   

For further information, please contact:

Investors: Claus Højmark Jensen, tel.: +45 2325 1067

 

Vedhæftede filer:

BO_1627_UK_vF.pdf

Udgivet af: NPinvestordk

Seneste nyheder

17:46 Europa/lukning: RFK som USA's sundhedsminister var gift for medicinalaktierne
17:07 Fredagens aktier: Nedtur til medicinalaktierne trak C25 i laveste niveau i år
17:00 Fredagens obligationer: Renten hoppede på stedet trods stærke tal fra USA
15:52 Forventninger dæmpes: Nu kun "fifty-fifty" om Fed sænker renten i december
15:39 USA/åbning: Kommentar fra Powell om renteudsigterne presser aktierne
15:08 Tørlastindekset Baltic Dry stiger for ottende gang på ni dage
14:00 USA/tendens: Powells rolige rentetilgang sender futures i rødt
13:55 DFDS-aktien i vejret efter alligevel at være kommet i mål med tyrkisk opkøb
13:16 Europa/aktier: Valg af vaccineskeptiker som USA's sundhedsminister tynger medicinal
13:14 DFDS køber alligevel tyrkisk virksomhed men på nye betingelser
13:07 SP Groups markante indtjeningsfremgang drevet af øget salg af egne varemærker
12:55 Trumps udnævnelse af kontroversiel sundhedsminister lægger pres på danske medicinalaktier
12:01 Obligationer/middag: Renten går et nøk ned inden amerikansk detailsalg
11:54 Aktier/middag: Bavarian får klø efter regnskab og kontroversielt ministervalg i USA
11:24 Efter en periode på sidelinjen anbefaler Danske Bank igen køb af NKT-aktien
11:12 Vi har rykket en del af julegaveindkøbene til andet kvartal siger MAtas-topchef
10:34 Bavarian Nordic løfter lidt af sløret for 2025: Har hentet ordrer for 2,4 mia. kr.
10:07 Topchef i Matas om omsætningsvækst: Flere nye varer, striber i Norden og hurtig levering
09:22 Bavarian dykker på bekymringer om 2025 og USA's nye sundhedsminister
09:20 Bavarian-aktie styrtdykker med 16 pct. efter regnskab og nyt fra USA